Below is a concise, mechanism‑focused rationale for why the HCC cell line SNU‑739 is exceptionally vulnerable to KDELR2 loss, tying your top dependencies and mutations to known KDELR2 biology.

What KDELR2 does that cancer cells can be addicted to
- ER chaperone retrieval and ER homeostasis: KDELR2 sits in the cis‑Golgi, binds KDEL‑motif ER chaperones (e.g., BiP/GRP78, GRP94, PDI, HSP47), and returns them to the ER via ARF1/COPI‑mediated retrograde transport. Binding is pH‑dependent and structurally defined. Disrupting KDELR2 depletes ER chaperones, impairs protein folding, and drives lethal ER stress. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30846601/?utm_source=openai))
- Signaling hub properties: Beyond trafficking, KDELRs act in a GPCR‑like manner to couple to Gαq/11, activating Src/ERK and FAK, and enhancing invadopodia‑dependent ECM degradation—behaviors often required by mesenchymal/EMT‑like tumor cells. Loss of KDELR2 therefore removes both a secretory “safety valve” and pro‑survival/pro‑invasive signaling. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3395092/?utm_source=openai))

Why SNU‑739, specifically, looks KDELR2‑addicted
- Direct codependency on early secretory retrograde traffic
  - ARF1 is a top dependency in SNU‑739—exactly the small GTPase that recruits COPI for KDELR‑driven Golgi→ER retrieval. Co‑dependence on KDELR2 and ARF1 is a classic signature of a cell whose viability hinges on continuous ER chaperone recycling. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC19122/?utm_source=openai))
- Heavy reliance on glycosylation and Golgi output
  - FUT8 (core fucosylation) and B4GAT1 (α‑dystroglycan priming) are in the top dependencies. Core fucosylation tunes signaling of multiple RTKs (EGFR, TGF‑βR, MET; and often PDGFR family), enabling proliferation/EMT; B4GAT1 is essential for functional α‑dystroglycan and adhesion to basement membrane. Cells that are “glyco‑addicted” are exquisitely sensitive to ER/Golgi stress and the loss of ER chaperone retrieval. ([breast-cancer-research.biomedcentral.com](https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-017-0904-8?utm_source=openai))
  - SNU‑739’s additional missense in ALG3 (an ER mannosyltransferase) may further narrow folding/glycosylation margins, making chaperone recycling via KDELR2 even more critical (even if that particular variant’s functional impact is uncertain in cancer). ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gtr/conditions/C1832736?utm_source=openai))
- Active autocrine/growth‑factor wiring that depends on a healthy secretory pathway
  - PDGFRB and FGF4 are top dependencies. Sustained RTK signaling typically requires correct N‑glycosylation and trafficking through ER/Golgi; KDELR2 safeguards this by recycling the ER folding machinery. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16316986/?utm_source=openai))
- EMT/invasion program that benefits from KDELR‑signaling
  - TWIST1 is a major dependency. TWIST1 drives EMT and integrin/FAK programs; KDELR‑dependent Src/FAK signaling and invadopodia maturation bolster matrix degradation and mesenchymal phenotypes. Removing KDELR2 can collapse both trafficking support and this pro‑invasive signaling axis. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26602382/?utm_source=openai))
- Baseline oxidative stress reliance that amplifies ER‑stress lethality
  - UCP3 and SOD2 are top dependencies, indicating SNU‑739 leans on mitochondrial anti‑ROS defenses. KDELR2 loss provokes ER stress/UPR, which propagates Ca2+/ROS stress to mitochondria; in a cell already dependent on UCP3/SOD2, that extra hit can be catastrophic. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/20493945/?utm_source=openai))
- HBV‑associated ER stress background in SNU‑739
  - SNU‑739 is an HBV‑integrated HCC line with HBV transcripts detected in its original characterization. HBV proteins (notably HBx and HBs) are well known to activate ATF6 and IRE1/XBP1 arms of the UPR and to perturb ER proteostasis. A pre‑stressed ER makes KDELR2‑mediated chaperone recycling non‑negotiable for survival. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4695537/?utm_source=openai))
- Secretory‑load link to mucin/ECM production
  - KDELR2 is required for mucin hypersecretion via IRE1α/XBP1s signaling in airway models, and for coordinating autophagy/lysosome repositioning that sustains secretion under load. This illustrates how KDELR2 buffers high‑throughput secretory states—precisely the context implied by SNU‑739’s dependency profile. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11451269/?utm_source=openai))

A unifying model for SNU‑739 KDELR2 hypersensitivity
1) Secretory addiction: SNU‑739 depends on high‑flux ER→Golgi→plasma membrane traffic to sustain growth‑factor (PDGFRB/FGF4) and adhesive/ECM programs (B4GAT1). KDELR2 ensures the ER remains stocked with KDEL‑chaperones; its loss rapidly depletes folding capacity and activates lethal UPR. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30846601/?utm_source=openai))  
2) Signaling addiction: KDELR‑Gαq/11→Src/FAK signaling integrates with EMT/TWIST1 programs; knocking out KDELR2 removes a pro‑proliferative, pro‑invasive signal input. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3395092/?utm_source=openai))  
3) Redox fragility: UCP3/SOD2 dependencies indicate a ROS‑prone state; KDELR2 loss escalates ER‑mitochondria stress crosstalk (PERK/MAMs), pushing cells over an apoptotic threshold. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/22705852/?utm_source=openai))  
4) HBV legacy: HBV integration and UPR activation in HBV‑related HCCs sensitizes cells to perturbations of ER quality control—making KDELR2 indispensable. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4695537/?utm_source=openai))

How your mutation list fits (high‑confidence and plausible links)
- Wnt/EMT bias: DVL1 p.G685R and AXIN2 p.I144T suggest Wnt pathway dysregulation, which cooperates with TWIST1 to drive EMT—an invasive, secretory state that benefits from KDELR‑dependent signaling. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26602382/?utm_source=openai))
- Glyco‑stress margin: ALG3 p.G313E (missense) sits in the dolichol‑linked N‑glycan assembly pathway; even modest impairment can increase reliance on ER chaperones and retrieval. This is consistent—but would need functional validation in SNU‑739. ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gtr/conditions/C1832736?utm_source=openai))
- DNA‑repair (BRCA2 p.R3384Ter; HROB p.E157Ter) and TP53 p.S215R are unlikely to directly create KDELR2 addiction, but they can heighten proteostatic/oxidative stress and limit adaptation to ER stress, compounding vulnerability.

Testable predictions you can check in SNU‑739
- Acute KDELR2 KO should cause rapid: (i) loss/mislocalization of ER KDEL‑chaperones; (ii) XBP1s induction and CHOP upregulation; (iii) mitochondrial ROS burst and apoptosis; and (iv) collapse of ECM‑degradation/invadopodia markers. Rescue by KDELR1/3 overexpression or by dampening UPR (e.g., PERK inhibition) should partially mitigate toxicity. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11406585/?utm_source=openai))
- ARF1 or COPI perturbation should phenocopy KDELR2 loss; conversely, supplementing chemical chaperones should partially rescue. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC19122/?utm_source=openai))

Context for SNU‑739 identity
- SNU‑739 is a hepatocellular carcinoma line (male, HBV‑positive origin; HBV DNA integrated with HBx/HBs/HBc transcripts at derivation), aligning with the HBV/ER‑stress background noted above. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4695537/?utm_source=openai))

Bottom line
SNU‑739’s top dependencies (KDELR2, ARF1, FUT8, B4GAT1, PDGFRB/FGF4, TWIST1, SOD2/UCP3) collectively point to a mesenchymal, highly secretory, glyco‑addicted and redox‑fragile state. KDELR2 sits at the convergence of these pressures: it maintains ER folding capacity through ARF1/COPI‑driven chaperone retrieval while providing pro‑survival Src/FAK signaling. Removing KDELR2 collapses both proteostasis and signaling supports, producing the “super‑sensitivity” you observe. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30846601/?utm_source=openai))

References (selected, for the mechanistic points above)
- KDELR2 structure/function and pH‑dependent KDEL capture; ARF1/COPI recruitment: Brauer et al., Science 2019; Lewis et al., EMBO J 1997; Majoul et al., J Cell Biol 1998. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/30846601/?utm_source=openai))
- GPCR‑like signaling to Gαq/11→Src/FAK; invadopodia/ECM degradation: Cancino/Luini labs, EMBO J 2012; J Cell Sci 2018; Oncogenesis/J Cell Sci 2014–2015. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3395092/?utm_source=openai))
- KDELR2–HSP47 axis and secretory collagen quality control (illustrating chaperone recycling necessity): AJHG 2020. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7675035/?utm_source=openai))
- KDELR‑dependent secretory “buffering” via autophagy/lysosome repositioning: Nat Commun 2019. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6374470/?utm_source=openai))
- FUT8/EMT/RTK signaling; B4GAT1/α‑dystroglycan: JBC 2005; Breast Cancer Res 2017; eLife 2014. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16316986/?utm_source=openai))
- UCP3/SOD2 in ROS control; ER‑mitochondria stress crosstalk: J Biol Chem 2010; Cell Death Discov/others; PERK at MAMs. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/20493945/?utm_source=openai))
- HBV/UPR activation and SNU‑739 HBV status: WJG/PMC 2001; ATF6 and IRE1/XBP1 activation by HBx. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4695537/?utm_source=openai))
- KDELR2 required for mucin hypersecretion via IRE1α/XBP1s (illustrative of secretory‑load dependence): J Cell Mol Med 2024. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11451269/?utm_source=openai))

If helpful, I can sketch specific assays and a short, 1‑page experimental plan to validate this model in SNU‑739 (immunofluorescence for GRP78/HSP47 redistribution, XBP1 splicing qPCR, mito‑ROS by MitoSOX, gelatin degradation assay for invadopodia, and rescue epistasis with KDELR1/3 or PERK/XBP1 modulators).